Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 278

1.

Influence of genetic variants on childhood lung functionThe Generation R Study.

Shagiwal S, den Dekker HT, de Jongste JC, Brusselle GG, Jaddoe VWV, Felix JF, Duijts L.

Pediatr Allergy Immunol. 2018 Jun 7. doi: 10.1111/pai.12931. [Epub ahead of print] Review.

PMID:
29882296
2.

Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study.

de Roos EW, Lahousse L, Verhamme KMC, Braunstahl GJ, Ikram MA, In 't Veen JCCM, Stricker BHC, Brusselle GGO.

Respir Med. 2018 Jun;139:6-12. doi: 10.1016/j.rmed.2018.04.006. Epub 2018 Apr 11.

PMID:
29858003
3.

Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.

Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, Zhu H, Hamilton JD, Swanson BN, Khan A, Chao J, Staudinger H, Pirozzi G, Antoni C, Amin N, Ruddy M, Akinlade B, Graham NMH, Stahl N, Yancopoulos GD, Teper A.

N Engl J Med. 2018 May 21. doi: 10.1056/NEJMoa1804093. [Epub ahead of print]

4.

Insights in particulate matter-induced allergic airway inflammation: Focus on the epithelium.

De Grove KC, Provoost S, Brusselle GG, Joos GF, Maes T.

Clin Exp Allergy. 2018 May 17. doi: 10.1111/cea.13178. [Epub ahead of print] Review.

PMID:
29772098
5.

Serum phosphate levels are related to all-cause, cardiovascular and COPD mortality in men.

Campos-Obando N, Lahousse L, Brusselle G, Stricker BH, Hofman A, Franco OH, Uitterlinden AG, Zillikens MC.

Eur J Epidemiol. 2018 May 15. doi: 10.1007/s10654-018-0407-7. [Epub ahead of print]

PMID:
29766437
6.

A Genome-Wide Linkage Study for Chronic Obstructive Pulmonary Disease in a Dutch Genetic Isolate Identifies Novel Rare Candidate Variants.

Nedeljkovic I, Terzikhan N, Vonk JM, van der Plaat DA, Lahousse L, van Diemen CC, Hobbs BD, Qiao D, Cho MH, Brusselle GG, Postma DS, Boezen HM, van Duijn CM, Amin N.

Front Genet. 2018 Apr 19;9:133. doi: 10.3389/fgene.2018.00133. eCollection 2018.

7.

Blood eosinophil levels as a biomarker in COPD.

Brusselle G, Pavord ID, Landis S, Pascoe S, Lettis S, Morjaria N, Barnes N, Hilton E.

Respir Med. 2018 May;138:21-31. doi: 10.1016/j.rmed.2018.03.016. Epub 2018 Mar 15. Review.

PMID:
29724389
8.

Physical activity and cause-specific mortality: the Rotterdam Study.

Koolhaas CM, Dhana K, Schoufour JD, Lahousse L, van Rooij FJA, Ikram MA, Brusselle G, Tiemeier H, Franco OH.

Int J Epidemiol. 2018 Apr 16. doi: 10.1093/ije/dyy058. [Epub ahead of print]

PMID:
29672692
9.

New era for European Respiratory Society clinical practice guidelines: joining efficiency and high methodological standards.

Miravitlles M, Tonia T, Rigau D, Roche N, Genton C, Vaccaro V, Welte T, Gaga M, Brusselle G.

Eur Respir J. 2018 Mar 8;51(3). pii: 1800221. doi: 10.1183/13993003.00221-2018. Print 2018 Mar. No abstract available.

PMID:
29519905
10.

Sarcopenia and Its Clinical Correlates in the General Population: The Rotterdam Study.

Trajanoska K, Schoufour JD, Darweesh SK, Benz E, Medina-Gomez C, Alferink LJ, Lahousse L, Brusselle G, Stricker B, Darwish Murad S, Zillikens MC, Uitterlinden AG, Ikram MA, Franco OH, Rivadeneira F.

J Bone Miner Res. 2018 Mar 4. doi: 10.1002/jbmr.3416. [Epub ahead of print]

PMID:
29502340
11.

Understanding the role of the chromosome 15q25.1 in COPD through epigenetics and transcriptomics.

Nedeljkovic I, Carnero-Montoro E, Lahousse L, van der Plaat DA, de Jong K, Vonk JM, van Diemen CC, Faiz A, van den Berge M, Obeidat M, Bossé Y, Nickle DC, Consortium B, Uitterlinden AG, van Meurs JJB, Stricker BCH, Brusselle GG, Postma DS, Boezen HM, van Duijn CM, Amin N.

Eur J Hum Genet. 2018 May;26(5):709-722. doi: 10.1038/s41431-017-0089-8. Epub 2018 Feb 8.

12.

Association of innate defense proteins BPIFA1 and BPIFB1 with disease severity in COPD.

De Smet EG, Seys LJ, Verhamme FM, Vanaudenaerde BM, Brusselle GG, Bingle CD, Bracke KR.

Int J Chron Obstruct Pulmon Dis. 2017 Dec 19;13:11-27. doi: 10.2147/COPD.S144136. eCollection 2018.

13.

Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.

De Backer E, Gremonprez F, Brusselle G, Depuydt P, Van Dorpe J, Van Haverbeke C, Goeminne PC, Derom E.

Acta Clin Belg. 2017 Dec 29:1-5. doi: 10.1080/17843286.2017.1420521. [Epub ahead of print]

PMID:
29287518
14.

Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks.

Demenais F, Margaritte-Jeannin P, Barnes KC, Cookson WOC, Altmüller J, Ang W, Barr RG, Beaty TH, Becker AB, Beilby J, Bisgaard H, Bjornsdottir US, Bleecker E, Bønnelykke K, Boomsma DI, Bouzigon E, Brightling CE, Brossard M, Brusselle GG, Burchard E, Burkart KM, Bush A, Chan-Yeung M, Chung KF, Couto Alves A, Curtin JA, Custovic A, Daley D, de Jongste JC, Del-Rio-Navarro BE, Donohue KM, Duijts L, Eng C, Eriksson JG, Farrall M, Fedorova Y, Feenstra B, Ferreira MA; Australian Asthma Genetics Consortium (AAGC) collaborators, Freidin MB, Gajdos Z, Gauderman J, Gehring U, Geller F, Genuneit J, Gharib SA, Gilliland F, Granell R, Graves PE, Gudbjartsson DF, Haahtela T, Heckbert SR, Heederik D, Heinrich J, Heliövaara M, Henderson J, Himes BE, Hirose H, Hirschhorn JN, Hofman A, Holt P, Hottenga J, Hudson TJ, Hui J, Imboden M, Ivanov V, Jaddoe VWV, James A, Janson C, Jarvelin MR, Jarvis D, Jones G, Jonsdottir I, Jousilahti P, Kabesch M, Kähönen M, Kantor DB, Karunas AS, Khusnutdinova E, Koppelman GH, Kozyrskyj AL, Kreiner E, Kubo M, Kumar R, Kumar A, Kuokkanen M, Lahousse L, Laitinen T, Laprise C, Lathrop M, Lau S, Lee YA, Lehtimäki T, Letort S, Levin AM, Li G, Liang L, Loehr LR, London SJ, Loth DW, Manichaikul A, Marenholz I, Martinez FJ, Matheson MC, Mathias RA, Matsumoto K, Mbarek H, McArdle WL, Melbye M, Melén E, Meyers D, Michel S, Mohamdi H, Musk AW, Myers RA, Nieuwenhuis MAE, Noguchi E, O'Connor GT, Ogorodova LM, Palmer CD, Palotie A, Park JE, Pennell CE, Pershagen G, Polonikov A, Postma DS, Probst-Hensch N, Puzyrev VP, Raby BA, Raitakari OT, Ramasamy A, Rich SS, Robertson CF, Romieu I, Salam MT, Salomaa V, Schlünssen V, Scott R, Selivanova PA, Sigsgaard T, Simpson A, Siroux V, Smith LJ, Solodilova M, Standl M, Stefansson K, Strachan DP, Stricker BH, Takahashi A, Thompson PJ, Thorleifsson G, Thorsteinsdottir U, Tiesler CMT, Torgerson DG, Tsunoda T, Uitterlinden AG, van der Valk RJP, Vaysse A, Vedantam S, von Berg A, von Mutius E, Vonk JM, Waage J, Wareham NJ, Weiss ST, White WB, Wickman M, Widén E, Willemsen G, Williams LK, Wouters IM, Yang JJ, Zhao JH, Moffatt MF, Ober C, Nicolae DL.

Nat Genet. 2018 Jan;50(1):42-53. doi: 10.1038/s41588-017-0014-7. Epub 2017 Dec 22.

PMID:
29273806
15.

Measures of subclinical cardiac dysfunction and increased filling pressures associate with pulmonary arterial pressure in the general population: results from the population-based Rotterdam Study.

Billar RJ, Leening MJG, Merkus D, Brusselle GGO, Hofman A, Stricker BHC, Ghofrani HA, Franco OH, Gall H, Felix JF.

Eur J Epidemiol. 2018 Apr;33(4):403-413. doi: 10.1007/s10654-017-0341-0. Epub 2017 Dec 13.

16.

Pulmonary function and diffusion capacity are associated with pulmonary arterial systolic pressure in the general population: The Rotterdam Study.

Loth DW, Lahousse L, Leening MJG, Krijthe BP, Felix JF, Gall H, Hofman A, Ghofrani HA, Franco OH, Stricker BH, Brusselle GG.

Respir Med. 2017 Nov;132:50-55. doi: 10.1016/j.rmed.2017.09.009. Epub 2017 Sep 21.

PMID:
29229105
17.

Care pathways for the selection of a biologic in severe asthma.

Bousquet J, Brusselle G, Buhl R, Busse WW, Cruz AA, Djukanovic R, Domingo C, Hanania NA, Humbert M, Menzies Gow A, Phipatanakul W, Wahn U, Wechsler ME.

Eur Respir J. 2017 Dec 7;50(6). pii: 1701782. doi: 10.1183/13993003.01782-2017. Print 2017 Dec. No abstract available.

PMID:
29217605
18.

The Significance of Eosinophilic Inflammation in Chronic Obstructive Pulmonary Disease.

Cooper CB, Brusselle G, Pascoe SJ, Pavord ID.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):967-968. doi: 10.1164/rccm.201709-1797LE. No abstract available.

PMID:
29140724
19.

COPD GWAS variant at 19q13.2 in relation with DNA methylation and gene expression.

Nedeljkovic I, Lahousse L, Carnero-Montoro E, Faiz A, Vonk JM, de Jong K, van der Plaat DA, van Diemen CC, van den Berge M, Obeidat M, Bossé Y, Nickle DC, Consortium BIOS, Uitterlinden AG, van Meurs JBJ, Stricker BHC, Brusselle GG, Postma DS, Boezen HM, van Duijn CM, Amin N.

Hum Mol Genet. 2018 Jan 15;27(2):396-405. doi: 10.1093/hmg/ddx390.

20.

A qualitative interpretation of challenges associated with helping patients with multiple chronic diseases identify their goals.

Boeckxstaens P, Willems S, Lanssens M, Decuypere C, Brusselle G, Kühlein T, De Maeseneer J, De Sutter A.

J Comorb. 2016 Nov 14;6(2):120-126. doi: 10.15256/joc.2016.6.64. eCollection 2016.

21.

The Rotterdam Study: 2018 update on objectives, design and main results.

Ikram MA, Brusselle GGO, Murad SD, van Duijn CM, Franco OH, Goedegebure A, Klaver CCW, Nijsten TEC, Peeters RP, Stricker BH, Tiemeier H, Uitterlinden AG, Vernooij MW, Hofman A.

Eur J Epidemiol. 2017 Sep;32(9):807-850. doi: 10.1007/s10654-017-0321-4. Epub 2017 Oct 24.

22.

Personalized medicine with biologics for severe type 2 asthma: current status and future prospects.

Godar M, Blanchetot C, de Haard H, Lambrecht BN, Brusselle G.

MAbs. 2018 Jan;10(1):34-45. doi: 10.1080/19420862.2017.1392425. Epub 2017 Nov 14.

23.

DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients.

Seys LJM, Widagdo W, Verhamme FM, Kleinjan A, Janssens W, Joos GF, Bracke KR, Haagmans BL, Brusselle GG.

Clin Infect Dis. 2018 Jan 6;66(1):45-53. doi: 10.1093/cid/cix741.

PMID:
29020176
24.

microRNA profiling in lung tissue and bronchoalveolar lavage of cigarette smoke-exposed mice and in COPD patients: a translational approach.

Conickx G, Avila Cobos F, van den Berge M, Faiz A, Timens W, Hiemstra PS, Joos GF, Brusselle GG, Mestdagh P, Bracke KR.

Sci Rep. 2017 Oct 9;7(1):12871. doi: 10.1038/s41598-017-13265-8.

25.

After asthma: redefining airways diseases.

Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, Frey U, Gibson P, Heaney LG, Holt PG, Humbert M, Lloyd CM, Marks G, Martinez FD, Sly PD, von Mutius E, Wenzel S, Zar HJ, Bush A.

Lancet. 2018 Jan 27;391(10118):350-400. doi: 10.1016/S0140-6736(17)30879-6. Epub 2017 Sep 11. Review. No abstract available.

26.

Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis.

Melsens K, Vandecasteele E, Deschepper E, Badot V, Blockmans D, Brusselle G, De Langhe E, De Pauw M, Debusschere C, Decuman S, Deroo L, Houssiau F, Lenaerts J, Piette Y, Thevissen K, Vanthuyne M, Westhovens R, Wijnant S, De Keyser F, Smith V.

Acta Clin Belg. 2018 Apr;73(2):119-125. doi: 10.1080/17843286.2017.1372244. Epub 2017 Sep 11.

PMID:
28891418
27.

Stratification of eosinophilic asthma patients treated with reslizumab and GINA Step 4 or 5 therapy.

Brusselle G, Canvin J, Weiss S, Sun SX, Buhl R.

ERJ Open Res. 2017 Aug 17;3(3). pii: 00004-2017. doi: 10.1183/23120541.00004-2017. eCollection 2017 Jul.

28.

Adherence to the 2015 Dutch dietary guidelines and risk of non-communicable diseases and mortality in the Rotterdam Study.

Voortman T, Kiefte-de Jong JC, Ikram MA, Stricker BH, van Rooij FJA, Lahousse L, Tiemeier H, Brusselle GG, Franco OH, Schoufour JD.

Eur J Epidemiol. 2017 Nov;32(11):993-1005. doi: 10.1007/s10654-017-0295-2. Epub 2017 Aug 19.

29.

Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease.

Lahousse L, Seys LJM, Joos GF, Franco OH, Stricker BH, Brusselle GG.

Eur Respir J. 2017 Aug 10;50(2). pii: 1602470. doi: 10.1183/13993003.02470-2016. Print 2017 Aug.

30.

Genes and pathways underlying susceptibility to impaired lung function in the context of environmental tobacco smoke exposure.

de Jong K, Vonk JM, Imboden M, Lahousse L, Hofman A, Brusselle GG, Probst-Hensch NM, Postma DS, Boezen HM.

Respir Res. 2017 Jul 24;18(1):142. doi: 10.1186/s12931-017-0625-7.

31.

Blood eosinophil count and exacerbation risk in patients with COPD.

Kerkhof M, Sonnappa S, Postma DS, Brusselle G, Agustí A, Anzueto A, Jones R, Papi A, Pavord I, Pizzichini E, Popov T, Roche N, Ryan D, Thomas M, Vogelmeier C, Chisholm A, Freeman D, Bafadhel M, Hillyer EV, Price DB.

Eur Respir J. 2017 Jul 20;50(1). pii: 1700761. doi: 10.1183/13993003.00761-2017. Print 2017 Jul. No abstract available.

PMID:
28729477
32.

Taken to task: what is and is not an appropriate response to an ERS guidelines task force?

Joos G, Bush A, Burghuber OC, Robalo Cordeiro C, Gaga M, Gibson GJ, Gratziou C, Rigau D, Rohde G, Smyth D, Stolz D, Tonia T, Vestbo J, Welte T, Brusselle G, Miravitlles M.

Eur Respir J. 2017 Jul 13;50(1). pii: 1700952. doi: 10.1183/13993003.00952-2017. Print 2017 Jul. No abstract available.

PMID:
28705948
33.

Azithromycin in uncontrolled asthma.

Brusselle G, Pavord I.

Lancet. 2017 Aug 12;390(10095):629-630. doi: 10.1016/S0140-6736(17)31547-7. Epub 2017 Jul 4. No abstract available.

PMID:
28687412
34.

Erratum: Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study.

Gruffydd-Jones K, Brusselle G, Jones R, Miravitlles M, Baldwin M, Stewart R, Rigazio A, Davis E, Keininger DL, Price D.

NPJ Prim Care Respir Med. 2017 Jun 8;27:17004. doi: 10.1038/npjpcrm.2017.4.

35.

Pulmonary artery to aorta ratio and risk of all-cause mortality in the general population: the Rotterdam Study.

Terzikhan N, Bos D, Lahousse L, Wolff L, Verhamme KMC, Leening MJG, Felix JF, Gall H, Ghofrani HA, Franco OH, Ikram MA, Stricker BH, van der Lugt A, Brusselle G.

Eur Respir J. 2017 Jun 15;49(6). pii: 1602168. doi: 10.1183/13993003.02168-2016. Print 2017 Jun.

PMID:
28619955
36.

Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma.

Nelsen LM, Vernon M, Ortega H, Cockle SM, Yancey SW, Brusselle G, Albers FC, Jones PW.

Respir Med. 2017 Jul;128:42-49. doi: 10.1016/j.rmed.2017.04.015. Epub 2017 Apr 30.

PMID:
28610668
37.

The effects of lutein on respiratory health across the life course: A systematic review.

Melo van Lent D, Leermakers ETM, Darweesh SKL, Moreira EM, Tielemans MJ, Muka T, Vitezova A, Chowdhury R, Bramer WM, Brusselle GG, Felix JF, Kiefte-de Jong JC, Franco OH.

Clin Nutr ESPEN. 2016 Jun;13:e1-e7. doi: 10.1016/j.clnesp.2016.02.096. Epub 2016 Mar 26. Review.

PMID:
28531562
38.

Sputum Neutrophil Elastase as a Biomarker for Disease Activity in Bronchiectasis.

Brusselle GG, Van Braeckel E.

Am J Respir Crit Care Med. 2017 May 15;195(10):1289-1291. doi: 10.1164/rccm.201612-2476ED. No abstract available.

PMID:
28504604
39.

Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort.

Vandecasteele E, Drieghe B, Melsens K, Thevissen K, De Pauw M, Deschepper E, Decuman S, Bonroy C, Piette Y, De Keyser F, Brusselle G, Smith V.

Eur Respir J. 2017 May 11;49(5). pii: 1602275. doi: 10.1183/13993003.02275-2016. Print 2017 May.

PMID:
28495691
40.

Influence of chronic azithromycin treatment on the composition of the oropharyngeal microbial community in patients with severe asthma.

Lopes Dos Santos Santiago G, Brusselle G, Dauwe K, Deschaght P, Verhofstede C, Vaneechoutte D, Deschepper E, Jordens P, Joos G, Vaneechoutte M.

BMC Microbiol. 2017 May 10;17(1):109. doi: 10.1186/s12866-017-1022-6.

41.

Qualitative evaluation of the St George's Respiratory Questionnaire in patients with severe asthma.

Nelsen LM, Kimel M, Murray LT, Ortega H, Cockle SM, Yancey SW, Brusselle G, Albers FC, Jones PW.

Respir Med. 2017 May;126:32-38. doi: 10.1016/j.rmed.2017.02.021. Epub 2017 Feb 28.

PMID:
28427547
42.

Reslizumab in Eosinophilic Asthma: A Review.

Deeks ED, Brusselle G.

Drugs. 2017 May;77(7):777-784. doi: 10.1007/s40265-017-0740-2. Review.

PMID:
28421429
43.

Association between lutein intake and lung function in adults: the Rotterdam Study.

Melo van Lent D, Leermakers ET, Hofman A, Stricker BH, Brusselle GG, Franco OH, Lahousse L, Kiefte-de Jong JC.

Br J Nutr. 2017 Mar;117(5):720-730. doi: 10.1017/S0007114517000319. Epub 2017 Apr 5.

PMID:
28376947
44.

Reply: Direct Detection of Circulating MicroRNAs Unveiled the Absence of MicroRNA-218-5p in Smoker Subjects.

Conickx G, Mestdagh P, Vandesompele J, Brusselle GG, Bracke KR.

Am J Respir Crit Care Med. 2017 Aug 15;196(4):533. doi: 10.1164/rccm.201701-0224LE. No abstract available.

PMID:
28257234
45.

Sex-Specific Genetic Risk Factors for Chronic Obstructive Pulmonary Disease.

Brusselle GG, Lahousse L.

Am J Respir Cell Mol Biol. 2017 Mar;56(3):281-282. doi: 10.1165/rcmb.2016-0399ED. No abstract available.

PMID:
28248137
46.

Reduced Frizzled Receptor 4 Expression Prevents WNT/β-Catenin-driven Alveolar Lung Repair in Chronic Obstructive Pulmonary Disease.

Skronska-Wasek W, Mutze K, Baarsma HA, Bracke KR, Alsafadi HN, Lehmann M, Costa R, Stornaiuolo M, Novellino E, Brusselle GG, Wagner DE, Yildirim AÖ, Königshoff M.

Am J Respir Crit Care Med. 2017 Jul 15;196(2):172-185. doi: 10.1164/rccm.201605-0904OC.

PMID:
28245136
47.

Six-minute walk test in or out in evaluation of systemic sclerosis patients?

Vandecasteele E, Thevissen K, Melsens K, De Keyser F, De Pauw M, Deschepper E, Decuman S, Piette Y, Brusselle G, Smith V.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):122-129. Epub 2017 Feb 15.

PMID:
28229829
48.

Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis.

Hobbs BD, de Jong K, Lamontagne M, Bossé Y, Shrine N, Artigas MS, Wain LV, Hall IP, Jackson VE, Wyss AB, London SJ, North KE, Franceschini N, Strachan DP, Beaty TH, Hokanson JE, Crapo JD, Castaldi PJ, Chase RP, Bartz TM, Heckbert SR, Psaty BM, Gharib SA, Zanen P, Lammers JW, Oudkerk M, Groen HJ, Locantore N, Tal-Singer R, Rennard SI, Vestbo J, Timens W, Paré PD, Latourelle JC, Dupuis J, O'Connor GT, Wilk JB, Kim WJ, Lee MK, Oh YM, Vonk JM, de Koning HJ, Leng S, Belinsky SA, Tesfaigzi Y, Manichaikul A, Wang XQ, Rich SS, Barr RG, Sparrow D, Litonjua AA, Bakke P, Gulsvik A, Lahousse L, Brusselle GG, Stricker BH, Uitterlinden AG, Ampleford EJ, Bleecker ER, Woodruff PG, Meyers DA, Qiao D, Lomas DA, Yim JJ, Kim DK, Hawrylkiewicz I, Sliwinski P, Hardin M, Fingerlin TE, Schwartz DA, Postma DS, MacNee W, Tobin MD, Silverman EK, Boezen HM, Cho MH; COPDGene Investigators; ECLIPSE Investigators; LifeLines Investigators; SPIROMICS Research Group; International COPD Genetics Network Investigators; UK BiLEVE Investigators; International COPD Genetics Consortium.

Nat Genet. 2017 Mar;49(3):426-432. doi: 10.1038/ng.3752. Epub 2017 Feb 6.

49.

Reslizumab in patients with inadequately controlled late-onset asthma and elevated blood eosinophils.

Brusselle G, Germinaro M, Weiss S, Zangrilli J.

Pulm Pharmacol Ther. 2017 Apr;43:39-45. doi: 10.1016/j.pupt.2017.01.011. Epub 2017 Jan 31.

50.

Design of a frailty index among community living middle-aged and older people: The Rotterdam study.

Schoufour JD, Erler NS, Jaspers L, Kiefte-de Jong JC, Voortman T, Ziere G, Lindemans J, Klaver CC, Tiemeier H, Stricker B, Ikram AM, Laven JS, Brusselle GG, Rivadeneira F, Franco OH.

Maturitas. 2017 Mar;97:14-20. doi: 10.1016/j.maturitas.2016.12.002. Epub 2016 Dec 12.

PMID:
28159055

Supplemental Content

Loading ...
Support Center